Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Policy Tracker · Psilocybin · United States

Is psilocybin legal in Connecticut?

Not for the public — Connecticut allows psilocybin only in research, pilots or trials.

Recorded status

Research or task force only

In effect since 2026-06-04

Signed into law: SB00191 — An Act Concerning The Psychedelic-assisted Therapy Pilot Program. (Clinical Research, Jun 4, 2026).

Psilocybin remains a Schedule I substance under US federal law regardless of state rules.

Source

PoliPsy legislation tracker · polipsy.dev

Full details for subscribers

Quoted law sections, penalties and thresholds, bill progress, year-by-year timeline and clinical trials for Connecticut are free with a PSA newsletter subscription.